Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma.

Pipas JM, Zaki BI, McGowan MM, Tsapakos MJ, Ripple GH, Suriawinata AA, Tsongalis GJ, Colacchio TA, Gordon SR, Sutton JE, Srivastava A, Smith KD, Gardner TB, Korc M, Davis TH, Preis M, Tarczewski SM, Mackenzie TA, Barth RJ Jr.

Ann Oncol. 2012 Nov;23(11):2820-7. doi: 10.1093/annonc/mds109. Epub 2012 May 9.

2.

New directions in the management of advanced pancreatic cancer: a review.

Rocha-Lima CM.

Anticancer Drugs. 2008 Jun;19(5):435-46. doi: 10.1097/CAD.0b013e3282fc9d11. Review.

PMID:
18418211
3.

Emerging drugs in pancreatic cancer.

Ducreux M, Boige V, Malka D.

Expert Opin Emerg Drugs. 2004 May;9(1):73-89. Review.

PMID:
15155137
4.

Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody.

Needle MN.

Semin Oncol. 2002 Oct;29(5 Suppl 14):55-60. Review.

PMID:
12422314
5.

Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.

Silvestris N, Longo V, Cellini F, Reni M, Bittoni A, Cataldo I, Partelli S, Falconi M, Scarpa A, Brunetti O, Lorusso V, Santini D, Morganti A, Valentini V, Cascinu S.

Crit Rev Oncol Hematol. 2016 Feb;98:309-24. doi: 10.1016/j.critrevonc.2015.11.016. Epub 2015 Nov 23. Review.

PMID:
26653573
6.

Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.

Loehrer AP, Ferrone CR.

Dig Surg. 2016;33(4):343-50. doi: 10.1159/000445020. Epub 2016 May 25. Review.

PMID:
27216011
7.

Advanced-stage pancreatic cancer: therapy options.

Werner J, Combs SE, Springfeld C, Hartwig W, Hackert T, Büchler MW.

Nat Rev Clin Oncol. 2013 Jun;10(6):323-33. doi: 10.1038/nrclinonc.2013.66. Epub 2013 Apr 30. Review.

PMID:
23629472
8.

Neoadjuvant therapy for advanced pancreatic neuroendocrine tumors: an emerging treatment modality?

Perysinakis I, Aggeli C, Kaltsas G, Zografos GN.

Hormones (Athens). 2016 Jan-Mar;15(1):15-22. doi: 10.14310/horm.2002.1636. Review.

9.

Multidetector computed tomography during combined therapy for pancreatic adenocarcinoma.

Morgan DE, Texada JC, Canon CL, Lockhart ME, Posey JA 3rd, Vickers SM.

Clin Gastroenterol Hepatol. 2008 Aug;6(8):842-848.e3. doi: 10.1016/j.cgh.2008.03.023. Epub 2008 Jun 27. Review.

PMID:
18585978
10.

Nephrotoxicity of anticancer drugs--an underestimated problem?

Lameire N, Kruse V, Rottey S.

Acta Clin Belg. 2011 Sep-Oct;66(5):337-45. Review.

PMID:
22145268
11.

Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.

Loehrer AP, Kinnier CV, Ferrone CR.

Adv Surg. 2016 Sep;50(1):115-28. doi: 10.1016/j.yasu.2016.03.010. Epub 2016 Jul 7. Review. No abstract available.

PMID:
27520867

Supplemental Content

Support Center